Four-factor prothrombin complex concentrate improves thrombin generation and prothrombin time in patients with bleeding complications related to rivaroxaban: a single-center pilot trial
Bettina Schenk(Apple (Israel)), Mirjam Bachler(Innsbruck Medical University), Ronny Beer(The University of Sydney), Raimund Helbok(Johannes Kepler University of Linz), D Friès(Innsbruck Medical University), Stephanie Goerke(Innsbruck Medical University)
Cited by 26
Related Papers
Case-mix, care pathways, and outcomes in patients with traumatic brain injury in CENTER-TBI: a European prospective, multicentre, longitudinal, cohort study
|The Lancet Neurology|2019|502
Consensus Summary Statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care
|Neurocritical Care|2014|472
Recording, analysis, and interpretation of spreading depolarizations in neurointensive care: Review and recommendations of the COSBID research group
|Journal of Cerebral Blood Flow & Metabolism|2016|360
Consensus statement from the 2014 International Microdialysis Forum
|Intensive Care Medicine|2015|344